Bank of America
LAB icon

Bank of America’s Standard BioTools LAB Stock Holding History

Bank of America’s Portfolio LAB Stock Details LAB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$386K Sell
420,565
-290,492
-41% -$352K ﹤0.01% 5029
2025
Q4 		$910K Buy
711,057
+579,829
+442% +$779K ﹤0.01% 4584
2025
Q3 		$171K Sell
131,228
-6,032
-4% -$7.9K ﹤0.01% 6357
2025
Q2 		$165K Sell
137,260
-7,768
-5% -$8.61K ﹤0.01% 6272
2025
Q1 		$157K Sell
145,028
-77,823
-35% -$109K ﹤0.01% 6294
2024
Q4 		$390K Buy
222,851
+37,605
+20% +$70K ﹤0.01% 5725
2024
Q3 		$358K Sell
185,246
-72,434
-28% -$142K ﹤0.01% 5698
2024
Q2 		$456K Sell
257,680
-378,659
-60% -$926K ﹤0.01% 5400
2024
Q1 		$1.72M Buy
636,339
+554,781
+680% +$1.34M ﹤0.01% 4540
2023
Q4 		$180K Buy
81,558
+71,128
+682% +$152K ﹤0.01% 6119
2023
Q3 		$30.2K Buy
10,430
+9,901
+1,872% +$25.9K ﹤0.01% 6628
2023
Q2 		$1.02K Sell
529
-1,011
-66% -$2K ﹤0.01% 7242
2023
Q1 		$3K Buy
1,540
+1,106
+255% +$2.19K ﹤0.01% 7164
2022
Q4 		$508 Buy
434
+420
+3,000% +$517 ﹤0.01% 7429
2022
Q3 		$0 Sell
14
-784
-98% -$1.19K ﹤0.01% 8027
2022
Q2 		$1K Sell
798
-31,107
-97% -$76.9K ﹤0.01% 7871
2022
Q1 		$115K Buy
31,905
+2,709
+9% +$9.36K ﹤0.01% 6780
2021
Q4 		$115K Sell
29,196
-6,028
-17% -$28.2K ﹤0.01% 6819
2021
Q3 		$232K Sell
35,224
-2,954
-8% -$19.4K ﹤0.01% 6203
2021
Q2 		$236K Sell
38,178
-66,054
-63% -$353K ﹤0.01% 5984
2021
Q1 		$472K Buy
104,232
+38,710
+59% +$213K ﹤0.01% 5420
2020
Q4 		$393K Buy
65,522
+40,290
+160% +$265K ﹤0.01% 5163
2020
Q3 		$187K Sell
25,232
-41,803
-62% -$289K ﹤0.01% 5337
2020
Q2 		$268K Buy
67,035
+4,387
+7% +$15.3K ﹤0.01% 5050
2020
Q1 		$159K Buy
62,648
+25,521
+69% +$83.8K ﹤0.01% 5240
2019
Q4 		$129K Sell
37,127
-15,363
-29% -$54K ﹤0.01% 5874
2019
Q3 		$243K Buy
52,490
+3,655
+7% +$28.8K ﹤0.01% 5546
2019
Q2 		$602K Buy
48,835
+19,182
+65% +$244K ﹤0.01% 4934
2019
Q1 		$394K Buy
29,653
+15,204
+105% +$160K ﹤0.01% 5159
2018
Q4 		$125K Buy
14,449
+9,654
+201% +$75.2K ﹤0.01% 5798
2018
Q3 		$36K Sell
4,795
-12,931
-73% -$91.9K ﹤0.01% 6339
2018
Q2 		$106K Buy
17,726
+14,679
+482% +$83.7K ﹤0.01% 5764
2018
Q1 		$17K Sell
3,047
-1,517
-33% -$9.96K ﹤0.01% 6437
2017
Q4 		$27K Buy
4,564
+2,779
+156% +$15.2K ﹤0.01% 6321
2017
Q3 		$9K Buy
1,785
+1,651
+1,232% +$6.94K ﹤0.01% 6578
2017
Q2 		$0 Sell
134
-5,017
-97% -$23.8K ﹤0.01% 7064
2017
Q1 		$29K Buy
5,151
+724
+16% +$4.59K ﹤0.01% 6154
2016
Q4 		$32K Buy
4,427
+3,031
+217% +$19K ﹤0.01% 6121
2016
Q3 		$11K Sell
1,396
-982
-41% -$9.02K ﹤0.01% 6352
2016
Q2 		$22K Buy
2,378
+2,348
+7,827% +$22.1K ﹤0.01% 6201
2016
Q1 		$0 Sell
30
-769
-96% -$5.55K ﹤0.01% 7167
2015
Q4 		$9K Sell
799
-58,345
-99% -$573K ﹤0.01% 6720
2015
Q3 		$479K Buy
59,144
+53,652
+977% +$844K ﹤0.01% 4835
2015
Q2 		$133K Buy
5,492
+5,034
+1,099% +$159K ﹤0.01% 5454
2015
Q1 		$19K Buy
+458
New +$18.1K ﹤0.01% 6063
2014
Q4 		– Sell
-2,970
Closed -$73K – 7822
2014
Q3 		$73K Sell
2,970
-422
-12% -$11.9K ﹤0.01% 6247
2014
Q2 		$100K Buy
3,392
+3,217
+1,838% +$103K ﹤0.01% 6145
2014
Q1 		$8K Sell
175
-6,494
-97% -$286K ﹤0.01% 7246
2013
Q4 		$255K Buy
6,669
+6,287
+1,646% +$185K ﹤0.01% 5364
2013
Q3 		$8K Sell
382
-984
-72% -$19.3K ﹤0.01% 7242
2013
Q2 		$24K Buy
+1,366
New +$24K ﹤0.01% 6895

Other funds holding LAB

CC
Casdin Capital New York $1.32B AUM 76.62% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return
MCO
MAK Capital One New York $679M AUM 29.02% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
LFCM
Long Focus Capital Management San Juan, Puerto Rico $3.8B AUM 7.31% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
HBWM
Hollow Brook Wealth Management Katonah, New York $392M AUM 36.68% 1-Year Est. Return
Neuberger Berman Group
Neuberger Berman Group New York $131B AUM 28.36% 1-Year Est. Return

Bank of America's LAB Position: Q1 2026 in Review

Bank of America reduced its Standard BioTools (LAB) stake by 41% in Q1 2026, selling an estimated $352K and leaving 420,565 shares worth $386K. The position accounts for ﹤0.01% of the portfolio, ranked #5029.

Bank of America first reported a position in LAB in Q2 2013 and has held it in 51 quarters since. The position peaked at $1.72M in Q1 2024. 155 funds tracked by Wall St. Rank hold LAB as of Q1 2026.

  • Bank of America held 420,565 shares of Standard BioTools worth $386K as of Q1 2026.
  • Bank of America sold 290,492 Standard BioTools shares in Q1 2026, an estimated $352K.
  • Standard BioTools made up ﹤0.01% of Bank of America's portfolio in Q1 2026, its #5029 holding.
  • Bank of America first reported a position in Standard BioTools in Q2 2013 and has held it in 51 quarters since.
  • Bank of America's Standard BioTools position peaked at $1.72M in Q1 2024.
  • 155 funds tracked by Wall St. Rank held Standard BioTools as of Q1 2026.

Based on Bank of America's 13F filing for Q1 2026, filed 18 May 2026.